PAKIANATHAN DEEPIKA
Insider CIK 1270734 · OMED Director · ALXA Director · ALDR Director, 10% owner · TRIV 10% owner · TNDM 10% owner · CALA Director, 10% owner · KPTI Director · TBPH Director · SENS 10% owner · MREO Director · PRDS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 28,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 17,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 58,065 | — | $0 | 6,009 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 28,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 17,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 58,065 | — | — | 6,009 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 13,398 | — | $0 | 13,398 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2026-06-12 | 2026-06-16 | 6,009 | — | $0 | 64,074 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-05-21 | 2026-05-26 | 15,508 | — | $0 | 15,508 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-05-28 | 2025-05-29 | 4,600 | — | $0 | 4,600 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2025-05-19 | 2025-05-21 | 24,258 | — | $0 | 24,258 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-05-19 | 2025-05-21 | 10,649 | — | $0 | 58,065 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-08-22 | 2024-08-23 | 11,000 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-08-22 | 2024-08-23 | 5,500 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-08-22 | 2024-08-23 | 31,500 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-08-22 | 2024-08-23 | 55,000 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-08-22 | 2024-08-23 | 15,000 | — | $0 | 30,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-08-22 | 2024-08-23 | 55,000 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-08-22 | 2024-08-23 | 1,825 | $3.00 | $5.5K | 1,825 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-08-22 | 2024-08-23 | 105,244 | $4.43 | $466.2K | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-08-22 | 2024-08-23 | 6,492 | $1.84 | $11.9K | 8,317 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-08-22 | 2024-08-23 | 38,953 | $1.31 | $51.0K | 59,688 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-08-22 | 2024-08-23 | 12,418 | $2.72 | $33.8K | 20,735 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-08-22 | 2024-08-23 | 2,071 | $3.87 | $8.0K | 105,244 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-08-22 | 2024-08-23 | 43,485 | $0.94 | $40.9K | 103,173 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-07 | 2024-06-07 | 229,308 | $0.95 | $217.8K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-07 | 2024-06-07 | 2,240 | $0.95 | $2.1K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-06 | 2024-06-07 | 117,307 | $0.98 | $115.0K | 229,308 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-06 | 2024-06-07 | 1,145 | $0.98 | $1.1K | 2,240 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-05 | 2024-06-07 | 4,526 | $0.96 | $4.3K | 3,385 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-05 | 2024-06-07 | 463,518 | $0.96 | $445.0K | 346,615 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-04 | 2024-06-04 | 337,742 | $0.95 | $320.9K | 810,133 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-04 | 2024-06-04 | 3,298 | $0.95 | $3.1K | 7,911 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-03 | 2024-06-04 | 357,256 | $1.00 | $357.3K | 1,147,875 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-03 | 2024-06-04 | 3,488 | $1.00 | $3.5K | 11,209 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-05-31 | 2024-06-04 | 1,976 | $0.95 | $1.9K | 14,697 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-05-31 | 2024-06-04 | 202,418 | $0.95 | $192.3K | 1,505,131 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2024-05-29 | 2024-05-30 | 69,000 | — | $0 | 69,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 23,576 | — | $0 | 23,576 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2024-05-08 | 2024-05-10 | 10,537 | — | $0 | 47,416 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2023-05-24 | 2023-05-25 | 34,000 | — | $0 | 34,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-05-02 | 2023-05-04 | 22,044 | — | $0 | 22,044 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-05-02 | 2023-05-04 | 9,132 | — | $0 | 36,879 | SEC↗ |
| CALA Calithera Biosciences, Inc | S Sale | 2023-01-27 | 2023-01-31 | 1,172 | $0.39 | $457 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | S Sale | 2023-01-27 | 2023-01-31 | 120,161 | $0.39 | $46.9K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-10 | 2022-06-10 | 1,294 | $6.00 | $7.8K | 1,707,549 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-10 | 2022-06-10 | 13 | $6.00 | $78 | 16,673 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-09 | 2022-06-10 | 209,455 | $6.18 | $1.29M | 1,708,843 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-09 | 2022-06-10 | 2,045 | $6.18 | $12.6K | 16,686 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-08 | 2022-06-10 | 322,825 | $6.50 | $2.10M | 1,918,298 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-08 | 2022-06-10 | 3,152 | $6.50 | $20.5K | 18,731 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-05-19 | 2022-05-20 | 23,900 | — | $0 | 23,900 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 28,000 | — | $0 | 28,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2022-04-26 | 2022-04-28 | 9,852 | — | $0 | 27,747 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion deriv | 2021-12-23 | 2021-12-28 | 52,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion deriv | 2021-12-23 | 2021-12-30 | 30,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion | 2021-12-23 | 2021-12-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion | 2021-12-23 | 2021-12-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-05-21 | 2021-05-21 | 23,900 | — | $0 | 23,900 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2021-04-27 | 2021-04-29 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2021-04-27 | 2021-04-29 | 9,828 | — | $0 | 17,895 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2020-07-01 | 2020-07-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2020-07-01 | 2020-07-06 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2020-07-01 | 2020-07-06 | 8,067 | — | $0 | 8,067 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2020-06-09 | 2020-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-05-21 | 2020-05-26 | 16,400 | — | $0 | 16,400 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-06-06 | 2019-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2019-05-30 | 2019-06-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | U Tender | 2019-04-23 | 2019-04-23 | 1,991,602 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | U Tender | 2019-04-23 | 2019-04-23 | 18,940 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-06-19 | 2018-06-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2018-05-31 | 2018-06-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2018-05-23 | 2018-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2017-06-15 | 2017-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2017-06-09 | 2017-06-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2017-05-24 | 2017-05-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 3,991 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 11,606 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 12,500 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 12,500 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 625 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 625 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 625 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 625 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | D To issuer deriv | 2016-06-21 | 2016-06-21 | 3,125 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | U Tender | 2016-06-21 | 2016-06-21 | 658 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | U Tender | 2016-06-21 | 2016-06-21 | 98,967 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2016-06-16 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2016-06-14 | 2016-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2016-05-26 | 2016-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SENS Senseonics Holdings, Inc. | P Buy | 2016-03-23 | 2016-03-23 | 11,875 | $2.85 | $33.8K | 109,725 | SEC↗ |
| SENS Senseonics Holdings, Inc. | P Buy | 2016-03-23 | 2016-03-23 | 1,216,195 | $2.85 | $3.47M | 11,237,221 | SEC↗ |
| TRIV TriVascular Technologies, | U Tender | 2016-02-03 | 2016-02-05 | 3,535,910 | — | $0 | 0 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2015-06-23 | 2015-06-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 11,000 | — | $0 | 11,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-05-22 | 2015-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2015-05-19 | 2015-05-21 | 6,350 | — | $0 | 6,350 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2015-01-12 | 2015-01-14 | 440 | $33.00 | $14.5K | 21,883 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2015-01-12 | 2015-01-14 | 45,014 | $33.00 | $1.49M | 2,241,123 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 415,128 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 6,808 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 4,053 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 740,312 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 7,228 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 745,825 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 7,282 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 66 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 66 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 7,282 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 745,825 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 415,128 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 4,053 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 740,312 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 7,228 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 6,808 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion | 2014-10-07 | 2014-10-09 | 1,908,073 | — | $0 | 1,908,073 | SEC↗ |
| CALA Calithera Biosciences, Inc | P Buy | 2014-10-07 | 2014-10-09 | 4,835 | $10.00 | $48.4K | 23,464 | SEC↗ |
| CALA Calithera Biosciences, Inc | P Buy | 2014-10-07 | 2014-10-09 | 495,165 | $10.00 | $4.95M | 2,403,238 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion | 2014-10-07 | 2014-10-09 | 18,629 | — | $0 | 18,629 | SEC↗ |
| CALA Calithera Biosciences, Inc | P Buy | 2014-10-07 | 2014-10-09 | 4,835 | $10.00 | $48.4K | 23,464 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion | 2014-10-07 | 2014-10-09 | 1,908,073 | — | $0 | 1,908,073 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion | 2014-10-07 | 2014-10-09 | 18,629 | — | $0 | 18,629 | SEC↗ |
| CALA Calithera Biosciences, Inc | P Buy | 2014-10-07 | 2014-10-09 | 495,165 | $10.00 | $4.95M | 2,403,238 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2014-08-21 | 2014-08-21 | 21,402 | $18.98 | $406.2K | 1,991,602 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2014-08-21 | 2014-08-21 | 201 | $18.98 | $3.8K | 18,940 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2014-08-20 | 2014-08-21 | 45,630 | $19.00 | $867.0K | 1,970,200 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2014-08-20 | 2014-08-21 | 429 | $19.00 | $8.2K | 18,739 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2014-08-19 | 2014-08-21 | 116 | $18.89 | $2.2K | 18,310 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2014-08-19 | 2014-08-21 | 12,425 | $18.89 | $234.7K | 1,924,570 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2014-07-08 | 2014-07-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2014-06-10 | 2014-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-23 | 2014-05-23 | 1,752 | $26.45 | $46.3K | 2,196,109 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-23 | 2014-05-23 | 17 | $26.45 | $450 | 21,443 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-22 | 2014-05-23 | 19,807 | $26.09 | $516.8K | 2,194,357 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-22 | 2014-05-23 | 193 | $26.09 | $5.0K | 21,426 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-21 | 2014-05-23 | 91,754 | $26.19 | $2.40M | 2,174,550 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-21 | 2014-05-23 | 896 | $26.19 | $23.5K | 21,233 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 20,835 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 3,803 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 380,353 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 2,083,541 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 20,835 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 3,803 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 2,083,541 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 380,353 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | P Buy | 2014-05-13 | 2014-05-15 | 3,465 | $10.00 | $34.6K | 2,838,532 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | P Buy | 2014-05-13 | 2014-05-15 | 346,535 | $10.00 | $3.47M | 2,835,067 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion | 2014-05-13 | 2014-05-15 | 24,638 | — | $0 | 2,488,532 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion | 2014-05-13 | 2014-05-15 | 2,463,894 | — | $0 | 2,463,894 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | P Buy | 2014-05-13 | 2014-05-15 | 3,465 | $10.00 | $34.6K | 2,838,532 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | P Buy | 2014-05-13 | 2014-05-15 | 346,535 | $10.00 | $3.47M | 2,835,067 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion | 2014-05-13 | 2014-05-15 | 2,463,894 | — | $0 | 2,463,894 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion | 2014-05-13 | 2014-05-15 | 24,638 | — | $0 | 2,488,532 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 970,167 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 45,094 | $15.81 | $712.9K | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 45,094 | — | $0 | 45,094 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 424,918 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 384,594 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 574,933 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-24 | 347,965 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-24 | 424,918 | — | $0 | 2,217,778 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-24 | 970,167 | — | $0 | 3,187,945 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-24 | 347,965 | — | $0 | 3,535,910 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-24 | 384,594 | — | $0 | 1,792,860 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-24 | 833,333 | $12.00 | $10.00M | 833,333 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-24 | 574,933 | — | $0 | 1,408,266 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2013-12-05 | 2013-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-21 | 48,558 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-21 | 1,113,545 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-21 | 10,871 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-21 | 4,973,160 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-21 | 3,632,552 | — | $0 | 3,632,552 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-21 | 35,467 | — | $0 | 35,467 | SEC↗ |
| KPTI Karyopharm Therapeutics In | C Conversion deriv | 2013-11-12 | 2013-11-14 | 1,500,500 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | C Conversion deriv | 2013-11-12 | 2013-11-14 | 14,652 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | C Conversion deriv | 2013-11-12 | 2013-11-14 | 2,663 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | C Conversion deriv | 2013-11-12 | 2013-11-14 | 272,818 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2013-11-12 | 2013-11-14 | 309,478 | $16.00 | $4.95M | 2,082,796 | SEC↗ |
| KPTI Karyopharm Therapeutics In | C Conversion | 2013-11-12 | 2013-11-14 | 17,315 | — | $0 | 17,315 | SEC↗ |
| KPTI Karyopharm Therapeutics In | C Conversion | 2013-11-12 | 2013-11-14 | 1,773,318 | — | $0 | 1,773,318 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2013-11-12 | 2013-11-14 | 3,022 | $16.00 | $48.4K | 20,337 | SEC↗ |
| TRIV TriVascular Technologies, | A Award deriv | 2013-11-01 | 2014-04-24 | 347,965 | — | $0 | 347,965 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,533,018 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 14,968 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 3,226 | $17.00 | $54.8K | 18,194 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 14,968 | — | $0 | 14,968 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 379,127 | $17.00 | $6.45M | 1,912,145 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,533,018 | — | $0 | 1,533,018 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2013-05-21 | 2013-05-22 | 11,606 | — | $0 | 11,606 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2012-06-06 | 2012-06-08 | 39,918 | — | $0 | 39,918 | SEC↗ |